(HealthDay News) — Weight-loss treatments may help lower the risk for obesity-related cancers in people with obesity and type 2 diabetes, according to a study published online Sept. 3 in Diabetes, ...

(HealthDay News) — The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before surgery rose 16-fold among patients undergoing metabolic and bariatric surgery from 2020 to 2024, according ...

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

Prostate cancer patients who closely follow ACS guidelines after diagnosis have lower all-cause and cardiovascular mortality than those who do not.

Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c. (HealthDay News) — Continuous glucose monitors (CGMs) do not accurately reflect blood sugar control ...

Men and women reporting overweight, respectively, are 19.14 and 11.44 times more likely to meet criteria for UPF addiction.

(HealthDay News) — Incidence and mortality from renal cancer (RC) may double by 2050, according to a study published in the October issue of European Urology.

In a separate update, the CDC also accepted a panel recommendation that children under age 4 receive their first chickenpox (varicella) shot separately from the combined measles, mumps, rubella and ...

A black box warning is the FDA’s most stringent for a prescription drug or medical device. Since 2003, it has appeared on all estrogen menopause drugs. It warns of risks such as breast and uterine ...

The Food and Drug Administration has approved Enoby, a biosimilar to Prolia, and Xtrenbo, a biosimilar to Xgeva.

In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy.